ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

7 hedge funds and large institutions have $1.67M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$149K
Puts
$487K
Net Calls
Net Calls Change

Top Buyers

1
+$691K
2
+$313K
3
+$11.6K
4
Simplex Trading
Simplex Trading
Illinois
+$8K

Top Sellers

1
-$65K
2
-$9.68K
3
-$100
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$835K
2
$476K
3
$319K
4
$14K
5
$10K
6
$8K
7
$3K